Literature DB >> 31579294

A High-throughput and Pathophysiologically Relevant Astrocyte-motor Neuron Co-culture Assay for Amyotrophic Lateral Sclerosis Therapeutic Discovery.

Matthew J Stopford1, Scott P Allen1, Laura Ferraiuolo1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult onset neurological disorder characterized by loss of motor neurons leading to progressive muscle wasting and eventually death. Astrocytes play a key role in disease pathogenesis. However, the ability to study astrocytic support towards motor neurons in ALS has been limited by a lack of sustainable high-throughput human cell models. Moreover, the ability to assess how astrocytic support of motor neurons is influenced by drug treatment or nutritional supplementation has been hampered by the lack of robust methodology. We have developed a high-throughput astrocyte motor neuron co-culture assay, which, by using Hb9-GFP+ motor neurons enables researchers to assess how ALS affects the ability of astrocytes to support motor neurons in 384-well plates. Moreover, astrocyte function can be manipulated by nutritional supplementation or drug treatment to identify possible therapeutic targets.

Entities:  

Keywords:  ALS; Astrocytes; Drug discovery; High-throughput drug screening; Motor neurons

Year:  2019        PMID: 31579294      PMCID: PMC6774773          DOI: 10.21769/BioProtoc.3353

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  19 in total

1.  Directed differentiation of embryonic stem cells into motor neurons.

Authors:  Hynek Wichterle; Ivo Lieberam; Jeffery A Porter; Thomas M Jessell
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

2.  Direct reprogramming of mouse fibroblasts to neural progenitors.

Authors:  Janghwan Kim; Jem A Efe; Saiyong Zhu; Maria Talantova; Xu Yuan; Shufen Wang; Stuart A Lipton; Kang Zhang; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-26       Impact factor: 11.205

3.  Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.

Authors:  André Varcianna; Monika A Myszczynska; Lydia M Castelli; Brendan O'Neill; Yeseul Kim; Jordan Talbot; Sophie Nyberg; Immanuelle Nyamali; Paul R Heath; Matthew J Stopford; Guillaume M Hautbergue; Laura Ferraiuolo
Journal:  EBioMedicine       Date:  2019-01-31       Impact factor: 8.143

4.  Necroptosis drives motor neuron death in models of both sporadic and familial ALS.

Authors:  Diane B Re; Virginia Le Verche; Changhao Yu; Mackenzie W Amoroso; Kristin A Politi; Sudarshan Phani; Burcin Ikiz; Lucas Hoffmann; Martijn Koolen; Tetsuya Nagata; Dimitra Papadimitriou; Peter Nagy; Hiroshi Mitsumoto; Shingo Kariya; Hynek Wichterle; Christopher E Henderson; Serge Przedborski
Journal:  Neuron       Date:  2014-02-06       Impact factor: 17.173

Review 5.  High-throughput drug screens for amyotrophic lateral sclerosis drug discovery.

Authors:  Alexander McGown; Matthew John Stopford
Journal:  Expert Opin Drug Discov       Date:  2018-10-13       Impact factor: 6.098

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.

Authors:  Laura Ferraiuolo; Kathrin Meyer; Thomas W Sherwood; Jonathan Vick; Shibi Likhite; Ashley Frakes; Carlos J Miranda; Lyndsey Braun; Paul R Heath; Ricardo Pineda; Christine E Beattie; Pamela J Shaw; Candice C Askwith; Dana McTigue; Brian K Kaspar
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-29       Impact factor: 11.205

8.  Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.

Authors:  Kathrin Meyer; Laura Ferraiuolo; Carlos J Miranda; Shibi Likhite; Sohyun McElroy; Samantha Renusch; Dara Ditsworth; Clotilde Lagier-Tourenne; Richard A Smith; John Ravits; Arthur H Burghes; Pamela J Shaw; Don W Cleveland; Stephen J Kolb; Brian K Kaspar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

9.  Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.

Authors:  Amanda M Haidet-Phillips; Mark E Hester; Carlos J Miranda; Kathrin Meyer; Lyndsey Braun; Ashley Frakes; SungWon Song; Shibi Likhite; Matthew J Murtha; Kevin D Foust; Meghan Rao; Amy Eagle; Anja Kammesheidt; Ashley Christensen; Jerry R Mendell; Arthur H M Burghes; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2011-08-10       Impact factor: 54.908

10.  SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits.

Authors:  Guillaume M Hautbergue; Lydia M Castelli; Laura Ferraiuolo; Alvaro Sanchez-Martinez; Johnathan Cooper-Knock; Adrian Higginbottom; Ya-Hui Lin; Claudia S Bauer; Jennifer E Dodd; Monika A Myszczynska; Sarah M Alam; Pierre Garneret; Jayanth S Chandran; Evangelia Karyka; Matthew J Stopford; Emma F Smith; Janine Kirby; Kathrin Meyer; Brian K Kaspar; Adrian M Isaacs; Sherif F El-Khamisy; Kurt J De Vos; Ke Ning; Mimoun Azzouz; Alexander J Whitworth; Pamela J Shaw
Journal:  Nat Commun       Date:  2017-07-05       Impact factor: 14.919

View more
  3 in total

1.  Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS.

Authors:  Yuri Ciervo; Noemi Gatto; Chloe Allen; Andrew Grierson; Laura Ferraiuolo; Richard J Mead; Pamela J Shaw
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-27       Impact factor: 6.698

Review 2.  Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models.

Authors:  Julie Bigarreau; Nathalie Rouach; Anselme L Perrier; Franck Mouthon; Mathieu Charvériat
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

3.  Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes.

Authors:  Cátia Gomes; Catarina Sequeira; Shibi Likhite; Cassandra N Dennys; Stephen J Kolb; Pamela J Shaw; Ana R Vaz; Brian K Kaspar; Kathrin Meyer; Dora Brites
Journal:  Cells       Date:  2022-04-01       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.